{"schema_version":"1","generated_at":"2026-11-05T04:26:22.747Z","data_as_of":null,"url":"https://www.findmykol.com/kol/ami-patel-ut","json_url":"https://www.findmykol.com/kol/ami-patel-ut/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"ami-patel-ut","name":"Ami Patel","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"city":"Salt Lake City","state":"UT","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1750675948"},"summary":"Ami Patel is a Hematology physician. ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04409639","title":"Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"University of Utah","source_url":"https://clinicaltrials.gov/study/NCT04409639","trial_url":"https://www.findmykol.com/trial/NCT04409639"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":9,"shown":3,"withheld":6,"rows":[{"payer":"Stemline Therapeutics Inc.","program_year":2025,"amount_usd":1705,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1750675948"},{"payer":"Genentech","program_year":2024,"amount_usd":62064.1,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1750675948"},{"payer":"Stemline Therapeutics Inc.","program_year":2024,"amount_usd":2480,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1750675948"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1750675948","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":56.5,"classes_total":4,"classes":[{"class":"Antimetabolite","setting":"prescribed","share_pct":23.5,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":null},{"class":"Interferon alfa-2b","setting":"prescribed","share_pct":13,"drugs":[{"name":"Besremi","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":31.3,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":31.3,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":12.2,"classes_total":1,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":12.2,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2022,"last":2026},"rows_total":5,"shown":3,"withheld":2,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"K08CA252883","title":"Mechanisms of resistance to MEK Inhibition in RAS-pathway activated chronic myelomonocytic leukemia","fiscal_year":2026,"amount_usd":"289908","organization":"UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH","source_url":"https://reporter.nih.gov/quickSearch/K08CA252883"},{"project":"K08CA252883","title":"Mechanisms of resistance to MEK Inhibition in RAS-pathway activated chronic myelomonocytic leukemia","fiscal_year":2025,"amount_usd":"289908","organization":"UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH","source_url":"https://reporter.nih.gov/quickSearch/K08CA252883"},{"project":"K08CA252883","title":"Mechanisms of resistance to MEK Inhibition in RAS-pathway activated chronic myelomonocytic leukemia","fiscal_year":2024,"amount_usd":"289908","organization":"UNIVERSITY OF UTAH","source_url":"https://reporter.nih.gov/quickSearch/K08CA252883"}],"source":"grants"},"contact":{"address_1":"2000 CIRCLE OF HOPE DR","address_2":"SUITE 2100","city":"Salt Lake City","state":"UT","zip":"84112","phone":"801-585-0120","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1750675948","source":"identity"},"similar":[{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":6,"funding":2}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-11-11","provider_certified":"2021-11-11","collected_at":"2026-11-04T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}